Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 06.11.2024
Viemed Healthcare Мультипликаторы 2011-2024 | VMD
Мультипликаторы по годам Viemed Healthcare
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
34.9 | 56.5 | 20.0 | 10.4 | 24.2 | - | - | - | - | - | - | - | - |
P/S |
2.0 | 2.5 | 1.6 | 2.5 | 2.6 | - | - | - | - | - | - | - | - |
EPS |
0.3 | 0.2 | 0.2 | 0.8 | 0.2 | 0.2 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
386 млн | 355 млн | 178 млн | 328 млн | 231 млн | 8.08 млн | 13.9 млн | 11.8 млн | - | - | - | - | - |
EBITDA per Share |
0.94 | 0.62 | 0.58 | 0.646 | 0.262 | - | - | - | - | - | - | - | - |
EV/EBITDA |
6.7 | 12.1 | 20.4 | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.04 | -1.63 | - | - | - | - | - | - | - | - | ||
P/B |
3.1 | 3.6 | 1.9 | 4.0 | 4.7 | - | - | - | - | - | - | - | - |
P/CF |
7.9 | 12.7 | 8.1 | 14.9 | 36.1 | - | - | - | - | - | - | - | - |
ROE % |
8.99 | 6.41 | 9.62 | 38.60 | 19.51 | - | - | - | - | - | - | - | - |
ROA % |
6.61 | 5.32 | 7.74 | 28.01 | 10.32 | - | - | - | - | - | - | - | - |
ROCE % |
11.67 | 8.40 | 11.56 | 27.31 | 16.27 | - | - | - | - | - | - | - | - |
Current Ratio |
3.8 | 5.9 | 5.1 | 2.0 | 1.1 | - | - | - | - | - | - | - | - |
DSO |
33.7 | 37.1 | 39.3 | 34.4 | 52.5 | - | - | - | - | - | - | - | - |
DIO |
21.3 | 20.3 | 19.9 | 16.5 | 20.5 | - | - | - | - | - | - | - | - |
DPO |
17.7 | 19.8 | 22.3 | 23.9 | 86.1 | - | - | - | - | - | - | - | - |
Операционный цикл |
55.0 | 57.4 | 59.2 | 50.9 | 72.9 | - | - | - | - | - | - | - | - |
Финансовый цикл |
37.3 | 37.5 | 36.9 | 27.0 | -13.2 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Viemed Healthcare
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.1 | 0.04 | 0.04 | - | 0.08 | 0.06 | 0.04 | - | 0.03 | 0.02 | 0.04 | - | 0.05 | 0.04 | 0.04 | 0.13 | 0.07 | 0.5 | 0.11 | 0.06 | 0.08 | 0.04 | 0.05 | 0.08 | 0.06 | 0.05 | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
0.15 | 0.1 | 0.22 | - | 0.12 | 0.08 | 0.18 | - | 0.33 | 0.03 | 0.14 | - | 0.28 | 0.07 | 0.1 | 0.13 | 0.28 | 0.44 | 0.18 | 0.07 | 0.17 | 0.12 | 0.1 | 0.08 | 0.13 | 0.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
8.39 | 7.97 | 8.97 | 6.43 | 7.55 | 5.99 | 4.80 | 4.00 | 6.00 | 6.88 | 7.65 | 5.84 | 12.04 | 13.47 | 35.42 | 38.60 | 37.85 | 40.95 | 20.22 | 19.51 | 23.16 | 22.96 | 25.92 | 30.42 | 21.31 | 14.97 | 8.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
6.17 | 5.84 | 6.51 | 4.73 | 5.62 | 4.55 | 4.46 | 3.84 | 5.39 | 4.58 | 5.99 | 4.45 | 8.96 | 9.90 | 25.73 | 28.01 | 26.40 | 27.36 | 11.72 | 10.32 | 12.96 | 13.65 | 15.97 | 19.07 | 13.53 | 9.39 | 5.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
12.39 | 11.67 | 11.37 | 7.95 | 9.43 | 7.35 | 5.96 | 4.78 | 7.84 | 9.42 | 11.22 | 7.40 | 13.28 | 14.73 | 26.22 | 29.91 | 28.77 | 28.12 | 16.69 | 15.63 | 19.43 | 22.45 | 25.77 | 30.68 | 22.12 | 15.25 | 8.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.0 | 3.8 | 4.0 | 3.8 | 3.7 | 3.3 | 5.1 | 5.9 | 4.7 | - | 5.2 | 5.1 | 4.4 | 4.5 | 3.8 | 3.6 | 3.6 | 3.6 | 3.6 | 2.1 | 2.1 | 2.1 | 2.1 | 2.5 | 2.9 | 2.9 | 2.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
42.6 | 42.8 | 38.7 | - | 33.1 | 36.0 | 36.6 | - | 19.1 | 18.6 | 37.4 | - | 38.7 | 42.3 | 41.2 | 36.2 | 33.8 | 26.4 | 45.8 | 49.1 | 51.7 | 51.8 | 51.3 | 43.9 | 47.6 | 58.6 | 34.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
16.9 | 18.1 | 19.7 | - | 22.1 | 21.0 | 20.6 | - | 10.3 | 8.8 | 18.1 | - | 21.7 | 22.3 | 19.4 | - | 15.1 | 12.4 | 20.3 | - | 19.6 | 21.8 | 38.4 | 54.4 | 64.2 | 52.8 | 25.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
23.8 | 25.1 | 21.9 | - | 29.4 | 27.7 | 20.3 | - | 12.1 | 13.1 | 25.3 | - | 30.1 | 23.3 | 19.8 | - | 13.7 | 11.3 | 37.6 | - | 67.9 | 75.4 | 95.8 | 110.8 | 130.9 | 94.5 | 35.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
59.4 | 60.9 | 58.4 | - | 55.2 | 57.0 | 57.2 | - | 29.4 | 27.5 | 55.5 | - | 60.4 | 64.6 | 60.5 | 36.2 | 48.8 | 38.8 | 66.1 | 49.1 | 71.3 | 73.6 | 89.8 | 98.3 | 111.9 | 111.4 | 60.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
35.6 | 35.8 | 36.5 | - | 25.8 | 29.4 | 36.9 | - | 17.3 | 14.4 | 30.2 | - | 30.3 | 41.3 | 40.8 | 36.2 | 35.1 | 27.5 | 28.5 | 49.1 | 3.4 | -1.8 | -6.0 | -12.5 | -19.0 | 16.9 | 24.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD